Quick-Med Technologies

What Quick-Med Technologies does

Quick-Med Technologies (OTCBB: QMDT) is a Gainesville, Florida-based life sciences company founded in 1997 that develops and licenses proprietary antimicrobial chemical technologies for medical, consumer, and industrial applications. The company's technology portfolio centers on two patented platforms: Nimbus, a non-leaching antimicrobial polymer based on poly(diallyldimethylammonium chloride) (polyDADMAC) that physically disrupts bacterial cell walls, and Stay Fresh (also branded Oxi-Tex), a sequestered hydrogen peroxide-based chemistry that degrades to water and oxygen. Both platforms are designed to kill bacteria without enabling antimicrobial resistance, a positioning validated by FDA De Novo clearance for Nimbus as a wound dressing in 2007 (K060662/DEN 070002). The company employs a small team of 1-10 scientists with expertise in materials chemistry and microbiology and operates from a laboratory co-located with University of Florida resources.

The commercial product portfolio includes Bioguard wound dressings (manufactured by Medline under license from Nimbus technology), DriGo-HP skinfold management textiles (Stay Fresh-based, distributed through Medline), antimicrobial ocular care solutions in development, antimicrobial textiles for medical scrubs and apparel, antimicrobial paints and coatings (developed with NSF support), and superabsorbent materials for feminine and incontinence care. The company generates revenue through three streams: technology licensing and royalties to OEM manufacturing partners, finished product sales through retail channels including Amazon, and technical services such as treatment optimization, regulatory guidance, and microbiological testing. Key enterprise and government customers include Medline, the US Air Force (antimicrobial airplane seat coatings), and consumer brands such as Thomson Tees.

Strategically, the company is positioned as a specialty R&D-driven licensor with deep regulatory and scientific credibility but limited scale, relying primarily on cumulative SBIR and NSF grant funding (over $2 million lifetime) rather than venture capital or private equity. Distribution is global through OEM partners, but the company itself remains a sub-10-person operation with publicly traded shares on the OTCBB.

Name

Quick-Med Technologies

Legal name

Quick-Med Technologies Inc.

Website

https://quickmedtech.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Quick-Med Technologies is a Gainesville, Florida-based life sciences company that develops and licenses proprietary non-leaching antimicrobial chemistries (Nimbus and Stay Fresh) for wound care, textiles, paints, and industrial applications, distributing globally through OEM partners such as Medline.

Ownership category

akta.pro rank

Product category

Antimicrobial chemical technologies

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Miscellaneous Chemical Products (2890)

akta.pro industry

PRIMARYHLAHANAE

Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables

SECONDARYCRADAMAB

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

SECONDARYIMAOADAD

Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)

Industrials, Manufacturing & Construction/Textiles, Apparel & Leather Manufacturing/Technical & Industrial Textiles Manufacturing

Keywords

• Antimicrobial chemical technologies
• Non-leaching wound dressings
• Sequestered hydrogen peroxide
• Medical device licensing
• Infection control materials

Headquarters

HQ city

Gainesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Technology Licensing and Distribution: Quick-Med Technologies licenses its proprietary antimicrobial chemical technologies (Nimbus, Stay Fresh) to manufacturing partners who incorporate them into end products. Products are distributed globally under their own brands and through partner brands.
2. Finished Product Sales: Direct sales of finished antimicrobial products including Bioguard wound dressings, DriGo-HP textiles, and Stay Fresh-treated consumer goods through retail channels and marketplaces.
3. Technical Services: Consulting and technical services including treatment optimization, laboratory prototyping, factory scale-up, regulatory guidance, microbiological testing, patent expertise, competing technology evaluations, and pricing evaluations.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

Quick-Med Technologies develops and licenses proprietary antimicrobial chemical technology platforms (Nimbus non-leaching polymer and Stay Fresh sequestered hydrogen peroxide) that are incorporated by manufacturing partners into wound dressings, medical textiles, apparel, ocular care solutions, paints, and coatings. The company also provides technical services including treatment optimization, laboratory prototyping to factory scale-up, regulatory guidance, and microbiological efficacy testing to enterprise and government clients.

Product overview

Quick-Med Technologies is a global distributor of antimicrobial chemical technologies offering two core patented technologies: Nimbus (a non-leaching antimicrobial polymer using polyDADMAC) and Stay Fresh (a sequestered hydrogen peroxide-based platform technology). These technologies are commercialized through multiple product lines including Bioguard wound dressings, DriGo-HP skinfold management textiles, antimicrobial ocular care solutions, antimicrobial textiles for medical and apparel use, and antimicrobial paints and coatings. The company also develops superabsorbent antimicrobial materials for feminine and incontinence care. Products are distributed globally with applications spanning consumer, industrial, and medical markets.

Differentiator

Problem solved

Functional benefit

Brands

• Nimbus: A patented non-leaching antimicrobial technology used in wound dressings and medical devices, based on polymeric quaternary biocidal molecule poly(diallyldimethylammonium chloride).
• Stay Fresh
• Oxi-Tex
• Bioguard
• DriGo-HP

Products and services

• Nimbus A patented antimicrobial polymer technology based on poly(diallyldimethylammonium chloride) (polyDADMAC) that is intrinsically bound to substrates, making it non-toxic and non-leaching. It is the only proven non-leaching antimicrobial wound dressing material and received FDA De Novo approval in 2007. Licensed to manufacturing partners for incorporation into wound dressings and medical devices.
• Stay Fresh A sequestered hydrogen peroxide-based antimicrobial platform technology that kills bacteria without causing antimicrobial resistance, degrades to water and oxygen, is biocompatible, and can be applied to textiles, paints, coatings, and other surfaces. Retains effectiveness through 75+ laundering cycles.
• Bioguard Wound Dressings A wound dressing based on Nimbus technology, manufactured by Medline. Biodegradable and non-toxic wound care solution that eliminates pathogens without allowing bacteria to develop resistance, making it safe for long-term use. Commercially available on Amazon and other platforms.
• DriGo-HP Skinfold Management Textile A skinfold management textile in the form of an antimicrobial wicking sheet using Stay Fresh technology. Eliminates MRSA, pseudomonas aeruginosa, E. coli, and SARS with greater than 99.99% effectiveness. Features ultra-smooth fabric that removes moisture from skin's surface.
• Antimicrobial Ocular Care Solutions Sterilization and preservative solutions for eye care using Nimbus antimicrobial technology. Designed to eliminate the need for toxic preservatives in eyedrop solutions while preventing bacterial growth in ocular care products.
• Antimicrobial Textiles Textiles treated with Stay Fresh antimicrobial technology for use in medical scrubs, linens, towels, airplane seats, and clothing items. Retains antimicrobial effectiveness through 75+ laundering cycles.
• Antimicrobial Paints and Coatings Paints and surface coatings infused with Stay Fresh antimicrobial technology. Long-lasting and regenerable, provides durable antimicrobial quality without introducing toxicity. Developed with NSF support.
• Superabsorbent Antimicrobial Materials Materials that absorb fluid, eliminate bacteria, yeast, and other microorganisms while preventing odor. Powered by hydrogen peroxide, using biocompatible materials suitable for feminine care and incontinence care products.
• Antimicrobial Technology Consulting Services Technical services provided to clients in consumer, industrial, and medical markets, including treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, competing technology evaluations, pricing evaluations, antimicrobials market evaluations, and scientific invention and original research.

Quantifiable outcome

• 99.99%+ effectiveness against MRSA, pseudomonas aeruginosa, E. coli, and SARS
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• US Air ForcecoreStrategic or Co-development PartnerQuick-Med Technologies collaborated with the US Air Force to apply their patented antimicrobial technology to airplane seats. The biomimetic textile coating kills antibacterial-resistant pathogens such as MRSA to 75+ launderings, mitigating spread of infectious disease while facilitating cost savings and human safety from toxic chemicals.
• MedlinecoreOEM/ Whitelabel/ Licensing PartnerMedline manufactures Bioguard wound dressings based on Quick-Med's trademark Nimbus technology. These biodegradable and nontoxic wound care solutions are commercially available through Amazon and other platforms. DriGo-HP products are also distributed through Medline's skin health channel.
• National Science Foundation (NSF)minorStrategic or Co-development PartnerStay Fresh paint technology is being developed with support from NSF, providing funding for research and development of antimicrobial paint and coating applications.
• University of FloridacoreStrategic or Co-development PartnerQuick-Med's primary laboratory is located in Gainesville with access to University of Florida resources in microbiology and materials chemistry. The partnership provides access to research facilities and academic expertise.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sciessent: Sciessent (formerly Agion) provides antimicrobial and odor-control technologies for textiles, medical devices, and industrial applications, offering a directly comparable licensing-based antimicrobial technology business model.
• Cupron: Cupron embeds copper-based antimicrobial properties into textiles, hard surfaces, and polymers for healthcare, consumer, and industrial applications — directly comparable antimicrobial material platform to Quick-Med's chemistries.
• PurThread Technologies: PurThread embeds antimicrobial (silver-copper) properties into fibers used in healthcare textiles and apparel, directly competing with Quick-Med's Nimbus and Stay Fresh antimicrobial textile offerings.
• BioCote: BioCote integrates antimicrobial technology into products including healthcare, consumer goods, and building materials via a partner/ licensing model — directly comparable to Quick-Med's Stay Fresh and Nimbus licensing approach.
• Applied Silver: Applied Silver (SilvaCoat) develops silver-ion based antimicrobial chemistries applied to textiles and surfaces, directly competing with Quick-Med's Nimbus and Stay Fresh in the antimicrobial-coating-for-textiles category.
• HeiQ Materials: HeiQ develops proprietary antimicrobial and material technologies for textiles, including healthcare apparel and consumer fabrics, with a licensing-driven business model overlapping Quick-Med's antimicrobial textile offerings.
• Microban International: Microban is one of the largest global suppliers of antimicrobial additives and technologies for consumer products, building products, and textiles — a broad incumbent directly comparable to Quick-Med's licensing model across consumer and industrial surfaces.

Broad incumbents

• SANITIZED AG: SANITIZED is a long-established Swiss provider of antimicrobial hygiene functions for textiles and polymers, representing a broad incumbent with comparable licensing-based antimicrobial technology offerings.

Regional players

• LifeBond (Life Sciences): LifeBond develops proprietary biomaterial-based wound care and tissue-sealing products, an adjacent wound-care medical device company that competes with Quick-Med's Bioguard wound dressing franchise in the advanced wound care market.

Emerging players

• Vestagen Protective Technologies: Vestagen develops antimicrobial and fluid-barrier technologies for healthcare worker apparel (e.g., VESTEX), a closely adjacent medical-textile niche to Quick-Med's Stay Fresh-treated medical scrubs and linens.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quick-Med Technologies